_    ___ ___      _                               
/ \ |_ _/ _ \ ___| |_ _ __ ___ __ _ _ __ ___ ___
/ _ \ | | | | / __| __| '__/ _ \/ _` | '_ ` _ \/ __|
/ ___ \ | | |_| \__ \ |_| | | __/ (_| | | | | | \__ \
/_/ \_\___\___/|___/\__|_| \___|\__,_|_| |_| |_|___/
Twitch
Invidious (YT)

Invidious > Channel > EBD Group

Trending
EBD Group 1100 subscribers    RSS
View channel on YouTube
Videos
Playlists

YT 7 minutes 38 seconds
EBD Group
BIO-Europe Spring® 2018: J&J Innovation talks CNS partnering and Alzheimer's challenges
YT 12 minutes 52 seconds
EBD Group
BIO-Europe Spring® 2018: Europe needs more patient capital to nurture biotechs
YT 12 minutes 8 seconds
EBD Group
BIO-Europe Spring® 2018: Crescendo aims to increase IO share of voice with Humabody platform
YT 6 minutes 30 seconds
EBD Group
BIO-Europe Spring® 2018: Defining AI and working with pharma, Mind the Byte CEO weighs in
YT 11 minutes 12 seconds
EBD Group
BIO-Europe Spring® 2018: Follicum details clinical progress of hair growth stimulating product
YT 8 minutes 20 seconds
EBD Group
BIO-Europe Spring® 2018: Zelluna Immunotherapy seeks TCR share of voice
YT 11 minutes 34 seconds
EBD Group
BIO-Europe Spring® 2018: Former EMA boss Lönngren proposes hard Brexit solution
YT 8 minutes 52 seconds
EBD Group
BIO-Europe Spring® 2018: Medicxi outlines growth ambitions for MG1 fund
YT 8 minutes 29 seconds
EBD Group
BIO-Europe Spring® 2018: Acesion tackles atrial fibrillation through SK channel inhibition
YT 8 minutes 14 seconds
EBD Group
BIO-Europe Spring® 2018: Herantis CEO outlines development plan for Parkinson's drug
YT 4 minutes 59 seconds
EBD Group
BIO-Europe Spring® 2018: Secarna MD on standing out in a crowd
YT 6 minutes 31 seconds
EBD Group
BIO-Europe Spring® 2018: Hercules muscles in on IO space with AhR inhibtor
YT 6 minutes 15 seconds
EBD Group
BIO-Europe Spring® 2018: What J&J gets out of JLABS incubators
YT 10 minutes 24 seconds
EBD Group
BIO-Europe Spring® 2018: BioNTech COO Sean Marett reveals how to spend $270M
YT 10 minutes 34 seconds
EBD Group
BIO-Europe Spring® 2018: Oncology Venture differentiates using big data systems biology
YT 7 minutes 43 seconds
EBD Group
BIO-Europe Spring® 2018: Genentech BD director reviews recent technology deals
YT 7 minutes 46 seconds
EBD Group
BIO-Europe Spring® 2018: Tilt arms oncolytic viruses to enable T-cell therapies
YT 5 minutes 41 seconds
EBD Group
BIO-Europe Spring® 2018: InteRNA CEO on cancer monotherapy ambition for lead drug
YT 5 minutes 9 seconds
EBD Group
BIO-Europe Spring® 2018: Advicenne CEO updates on Phase III rare disease program
YT 6 minutes 39 seconds
EBD Group
BIO-Europe Spring® 2018: UK Government strategy to back pharma falling on deaf ears